P

Inventor

DIMITROV DIMITER

US15 patents
⚠️ This page may combine multiple inventors who share the name “DIMITROV DIMITER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOMED VALLEY DISCOVERIES INC

8 patents
US10758614B2Sep 1, 2020

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

BIOMED VALLEY DISCOVERIES INC3 citations71
US11033621B2Jun 15, 2021

Combination therapies targeting tumor-associated stroma or tumor cells

BIOMED VALLEY DISCOVERIES INC0 citations60
US11033620B2Jun 15, 2021

Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

BIOMED VALLEY DISCOVERIES INC0 citations60
US11034757B2Jun 15, 2021

Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

BIOMED VALLEY DISCOVERIES INC0 citations50
US10799584B2Oct 13, 2020

Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

BIOMED VALLEY DISCOVERIES INC0 citations50
US10758613B2Sep 1, 2020

Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

BIOMED VALLEY DISCOVERIES INC0 citations50
US10758526B2Sep 1, 2020

Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

BIOMED VALLEY DISCOVERIES INC0 citations39
US10434174B2Oct 8, 2019

Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

BIOMED VALLEY DISCOVERIES INC0 citations39

US HEALTH

4 patents
US9765142B2Sep 19, 2017

TEM8 antibodies and their use in treatment and detection of tumors

US HEALTH31 citations93
US11680093B2Jun 20, 2023

Monoclonal antibodies that specifically bind to matrilin 3 and their use

US HEALTH0 citations56
US10196443B2Feb 5, 2019

TEM8 antibodies and their use in treatment and detection of tumors

US HEALTH0 citations51
US10323083B2Jun 18, 2019

Agents that specifically bind matrilin-3 and their use

US HEALTH0 citations46

CHILDRENS HOSPITAL PHILADELPHIA

1 patent
US11814440B2Nov 14, 2023

Glypican 2 as a cancer marker and therapeutic target

CHILDRENS HOSPITAL PHILADELPHIA1 citations56

THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT

1 patent
US10954291B2Mar 23, 2021

Monoclonal antibodies that specifically bind to matrilin-3 and their use

THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT0 citations55

DIMITROV DIMITER

1 patent
US9044457B2Jun 2, 2015

Anti-DR4 agonist antibodies

DIMITROV DIMITER0 citations44